LTC studies suggest antibodies from vaccines wane much faster in seniors: Task Force report

COVID-19 antibodies wane much faster than expected among seniors and those with comorbidities, according to the latest research on long-term care residents funded by the COVID-19 Immunity Task Force -- findings they say reinforce policy decisions and recommendations around providing booster shots to vulnerable populations.